LLY : NYSE
Industry: Pharmaceuticals

Balance Sheet
2008
12/31/08
2007
12/31/07
2006
12/31/06
2005
12/31/05
Cash5,4973,2203,1093,007
Short Term Investments4291,6117822,031
ASSETS
Cash & Short Term Investments5,9264,8313,8915,038
Receivables - Net3,2773,7052,6942,762
Raw Materials236203187215
Work in Progress1,6571,8031,5521,272
Finished Goods771653644471
Progress Payments Other(171)(135)(113)(80)
Inventories - Total2,4932,5242,2701,878
Prepaid Expenses375614320362
Other Current Assets382643519--
CURRENT ASSETS - TOTAL12,45312,3169,69410,796
Land219180169167
Buildings5,9535,5444,8534,585
Machinery & Equipment8,0457,4556,7186,314
Property, Plant and Equipment - Gross15,31614,84113,71713,136
Accumulated Depreciation(6,690)(6,266)(5,564)(5,223)
Property, Plant and Equipment - Net8,6268,5758,1527,913
Investments in Associated Companies1289988102
Other Investments1,4174789141,194
Deferred Charges--1,6701,0920
Other Tangible Assets2,5341,2811,8854,436
Total Intangible Other Assets - Net4,0542,455130140
Other Assets - Total6,5885,4063,107--
TOTAL ASSETS29,21326,87521,95524,581
LIABILITIES
Accounts Payable886924789781
Short Term Debt & Current Portion of Long Term Debt5,846414219735
Accrued Payroll771824608549
Income Taxes Payable229238641885
Dividends Payable537514463437
Other Current Liabilities4,8412,5232,365--
CURRENT LIABILITIES - TOTAL13,1105,4375,0855,716
Long Term Debt4,6164,5943,494--
Provision for Risks and Charges3,2942,3421,587--
Deferred Taxes - Credit7528862695
DEFERRED TAXES7528862695
Other Liabilities1,383711746--
TOTAL LIABILITIES22,47713,37110,97513,789
EQUITY
Non-Equity Reserves000--
Minority Interest000--
Preferred Stock000--
Common Stock711710708707
Capital Surplus3,9773,8053,5723,324
Other Appropriated Reserves(5,711)(3,787)(4,438)(2,838)
Retained Earnings7,65511,80710,92710,027
ESOP Guarantees8695101106
Unrealized Foreign Exchange Gain/Loss4011,150395(237)
Unrealized Gain/Loss on Marketable Securities(111)152020
Treasury Stock(99)(101)(101)(104)
COMMON EQUITY6,73513,50410,98110,792
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY29,21326,87521,955--
SHARE INFORMATION
Common Shares Outstanding1,1361,1341,1321,130
2009 Q3
9/30/09
2009 Q2
6/30/09
2009 Q1
3/31/09
2008 Q4
12/31/08
2008 Q3
9/30/08
Cash------5,497--
ASSETS
Cash & Short Term Investments3,9293,4903,5085,9266,119
Receivables - Net3,4833,3303,1603,2773,259
Inventories - Total3,1283,0002,5492,4932,112
Prepaid Expenses1,006825652375825
Other Current Assets264291391382631
CURRENT ASSETS - TOTAL11,81010,93510,26012,45312,946
Property, Plant and Equipment - Gross15,18915,21614,94315,31614,896
Accumulated Depreciation(6,956)(6,621)(6,493)(6,690)(6,634)
Property, Plant and Equipment - Net8,2338,5948,4508,6268,262
Investments in Associated Companies------128--
Total Intangible Other Assets - Net3,7393,7903,8584,0542,299
Other Assets - Total7,0857,4027,8868,0056,499
TOTAL ASSETS27,12826,93126,59729,21327,707
LIABILITIES
Accounts Payable8889191,023886854
Short Term Debt & Current Portion of Long Term Debt6221,0351,6035,846427
Income Taxes Payable276343710229404
Other Current Liabilities4,2814,6934,0236,1484,825
CURRENT LIABILITIES - TOTAL6,0686,9897,35813,1106,510
Long Term Debt6,7706,6886,8714,6164,186
Deferred Taxes - Credit102797275284
DEFERRED TAXES102797275284
Other Liabilities(1,784)4,6154,5714,6772,986
TOTAL LIABILITIES11,15518,37218,87222,47713,966
EQUITY
Non-Equity Reserves00000
Minority Interest400K(3)400
Preferred Stock00000
Common Stock719719719711711
Capital Surplus4,5604,4554,3613,9773,913
Retained Earnings9,9939,0498,9687,65512,336
Unrealized Foreign Exchange Gain/Loss------401--
Unrealized Gain/Loss on Marketable Securities------(111)--
Treasury Stock(99)(99)(99)(99)(99)
COMMON EQUITY9,9058,5637,7216,73513,742
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY27,12826,93126,59729,21327,707
SHARE INFORMATION
Common Shares Outstanding1,1491,1491,1491,1361,137
() = Negative Values
Values are displayed in Millions except for earnings per share and where noted